Acologix Hopes To Bring In $115M On Tokyo Exchange

With Japanese investors holding the majority of its shares and a lead product in-licensed from a Tokyo-based company, Acologix Inc. filed to conduct a $115 million initial public offering on the Tokyo Stock Exchange. (BioWorld Today)